Medical Technology Sector Reaches $325 Billion in Revenue
Global medical technology revenue grew by 7.1 percent in the first half of 2026 as M&A activity surged.
Updated on Oct. 20, 2026 in Healthcare
Live Poll
Do you trust that the increasing use of AI in medical devices will improve patient outcomes?
The global medtech industry generated $325 billion in revenue during the first half of 2026. This performance follows a strong 2025 where total annual revenue reached $650 billion, supported by an 11% growth rate.
Why it matters
Growth in the sector is largely driven by increased R&D investment and the rapid integration of artificial intelligence into clinical devices. This trend reflects a broader shift toward modernized healthcare infrastructure through technological innovation.
The medtech industry recorded $130 billion in total disclosed deal value, highlighted by Abbott acquiring Exact Sciences for $23 billion. Revenue for the first half of 2026 increased 7.1% compared to the same period in 2025.
The players
Abbott
Abbott is a global healthcare company that develops medical devices, diagnostics, and branded generic medicines.
Exact Sciences
Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of cancer.
Food and Drug Administration
The Food and Drug Administration is the United States federal agency responsible for regulating medical devices and ensuring public safety.
The details
Companies are fueling expansion by aggressively increasing dealmaking and embedding artificial intelligence into new devices and care pathways. The FDA authorized 331 AI-enabled medical devices in 2025, bringing the total to nearly 800 between 2022 and 2025.
Timeline
Between 2020 and 2022, the FDA authorized over 400 AI-enabled devices.
Between 2022 and 2025, the FDA authorized nearly 800 AI-enabled devices.
In 2025, total medtech industry revenue reached $650 billion.
The FDA authorized 331 AI-enabled devices throughout 2025.
In the first half of 2026, medtech revenue reached $325 billion.
Market Landscape
This consolidation and revenue growth mirror the rapid adoption of digital health tools across major markets like the US and Europe. The shift positions leading medtech firms to compete against emerging health-tech startups through large-scale acquisition strategies.
Consumers may notice a faster rollout of AI-integrated diagnostic and monitoring tools in clinical settings. These technological advancements aim to improve early detection and treatment options through more precise medical devices.
The takeaway
The medtech sector is increasingly defined by AI-driven innovation and significant capital investment in R&D. Stakeholders should anticipate continued merger activity as firms race to integrate new digital diagnostic capabilities.
Further reading
Explore more industry trends in the Healthcare section.
Live Poll
Do you trust that the increasing use of AI in medical devices will improve patient outcomes?
